TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,412,000 | +932.8% | 201,558 | +1734.2% | 0.02% | +1500.0% |
| Q4 2021 | $524,000 | -72.8% | 10,989 | -62.1% | 0.00% | -75.0% |
| Q3 2021 | $1,925,000 | -83.1% | 28,981 | -80.1% | 0.00% | -84.6% |
| Q2 2021 | $11,374,000 | -36.3% | 145,780 | -22.7% | 0.03% | -43.5% |
| Q1 2021 | $17,850,000 | +65.4% | 188,704 | +113.1% | 0.05% | +48.4% |
| Q4 2020 | $10,789,000 | +146.9% | 88,545 | +77.0% | 0.03% | +93.8% |
| Q3 2020 | $4,370,000 | -16.4% | 50,022 | -38.2% | 0.02% | -38.5% |
| Q2 2020 | $5,227,000 | – | 80,925 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |